| Stereochemistry | ACHIRAL |
| Molecular Formula | 2C10H9O2.2C2H5O.Ti |
| Molecular Weight | 460.343 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | -4 |
SHOW SMILES / InChI
SMILES
[Ti].CC[O-].CC[O-].CC(=O)[CH-]C(=O)C1=CC=CC=C1.CC(=O)[CH-]C(=O)C2=CC=CC=C2
InChI
InChIKey=KAPHMPHWLCJRRK-UHFFFAOYSA-N
InChI=1S/2C10H9O2.2C2H5O.Ti/c2*1-8(11)7-10(12)9-5-3-2-4-6-9;2*1-2-3;/h2*2-7H,1H3;2*2H2,1H3;/q4*-1;
| Molecular Formula | Ti |
| Molecular Weight | 47.867 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C10H10O2 |
| Molecular Weight | 162.1852 |
| Charge | 0 |
| Count |
MOL RATIO
2 MOL RATIO (average) |
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C2H5O |
| Molecular Weight | 45.0605 |
| Charge | -1 |
| Count |
MOL RATIO
2 MOL RATIO (average) |
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Budotitane [cis-diethoxybis(1-phenylbutane-1,3-dionato)titanium (IV)] is an inorganic titanium complex. The complex acts as a DNA intercalating agent thereby affecting cell proliferation. Preclinical studies in established screening models indicate considerable antitumor activity. Budotitane reached the end of phase I clinical trials for the treatment of solid tumors.
